Army enlistment waivers for cannabis

Quarterly Insights from the RAND Drug Policy Research Center | View in browser

Join RAND on Facebook Follow RAND on Twitter

Quarterly insights from the RAND Drug Policy Research Center

November 2021

Lt. Col. Scott Morley, commander of the Phoenix Recruiting Battalion, administers the oath of enlistment to 40 future soldiers, August 26, 2018, at Chase Field, photo by Mike Scheck/U.S. Army

Should Past Cannabis Use Prevent Individuals from Joining the Army?

Army recruits with a history of cannabis use can ask for a waiver like those who have diabetes or insomnia. They are just as likely as others to complete their first term and make sergeant, and are less likely to leave the Army for health or performance reasons. Read more »

Trays of injection materials are placed in cubicles at the SCMR (a supervised injection site) in Paris, France, October 11, 2016, photo by Patrick Kovarik/Pool/Reuters

Photo by Patrick Kovarik/Pool/Reuters

Treating Supervised Drug Consumption Sites Like Cannabis

Some communities hard hit by the overdose crisis are interested in opening supervised consumption sites—places where people who use drugs can do so under supervision of trained staff. What could be done to make it easier to pilot and evaluate these sites in the United States?

Read more »

Mother holding her newborn baby in the hospital, photo by kieferpix/Getty Images

Photo by kieferpix/Getty Images

Association of Neonatal Opioid Withdrawal Syndrome and Infant Foster Care Entry

Researchers examined the association of county rates of neonatal opioid withdrawal syndrome (NOWS) and county-level characteristics with infant foster care entries. One in every ten diagnosed NOWS births was associated with a 41 percent higher rate of infant foster care entry.

Read more »

Rehabilitation center room prepared for a group therapy session, photo by SolStock/Getty Images

Photo by SolStock/Getty Images

How Has COVID-19 Influenced Visits to Substance Use Treatment Facilities?

Using cell phone location data, researchers found that counties experiencing the most COVID-19 cases had a significantly greater reduction in the number of visits to substance use treatment facilities.

Read more »

Close up of a person pouring prescription pills into a hand, photo by Rattankun Thongbun/Getty Images

Photo by Rattankun Thongbun/Getty Images

Claims-Based Measures of Prescription Opioid Utilization: A Practical Guide for Researchers

RAND researchers reviewed medical literature for recent studies that use claims data to construct opioid utilization measures, then developed a guide for researchers regarding these measures and their definitions, and how they may influence study results.

Read more »

Trending Research

Changes in Adult Alcohol Use and Consequences During the COVID-19 Pandemic in the U.S.

Buprenorphine Prescriber Monthly Patient Caseloads: An Examination of 6-Year Trajectories

The Future of Fentanyl and Other Synthetic Opioids

DPRC in the News

'Sober October' Another Opportunity To Reexamine Alcohol Or Pot Habits


A Better Way to Legalize Marijuana


Fentanyl Is One Reason Why the U.S. Drug Addiction Crisis Is Roaring Back


In a Bid to Stop Overdose Deaths, California Could Allow Drug Use at Supervised Sites

Los Angeles Times


Beau Kilmer

Beau Kilmer

Director, RAND Drug Policy Research Center

McCauley Chair in Drug Policy Innovation, RAND